About Ejal 40
Ejal 40 is an advanced bio-revitalizing injectable developed by Medixa Srl, an Italian company specializing in innovative solutions for aesthetic and regenerative medicine. Formulated with a high concentration of medium-molecular-weight hyaluronic acid (40 mg/2 ml), Ejal 40 is designed to restore skin structure, improve elasticity, and stimulate the production of collagen and elastin. Its unique composition supports the physiological renewal of the extracellular matrix (ECM), making it an effective treatment for both prevention and correction of skin aging.
Rebuild, Strengthen, Renew -
Ejal 40 Features
Ejal 40 functions as a deep bio-restructuring treatment rather than a volumizing filler. Its balanced molecular weight hyaluronic acid penetrates effectively to hydrate, improve tissue density, and activate fibroblast activity. This process restores dermal thickness and elasticity while reducing fine lines and signs of laxity. Treatments are versatile and can be applied to the face, neck, décolleté, and hands, offering patients firmer, healthier, and more radiant skin.
Ejal 40 Product Highlights
- Ejal 40 Bio-Revitalizing Gel
- Contains 40 mg of medium-molecular-weight hyaluronic acid in 2 ml.
- Stimulates fibroblast activation, collagen synthesis, and ECM renewal.
- Improves hydration, firmness, and elasticity while reducing early and moderate wrinkles.
- Minimally invasive treatment with long-lasting natural results.
About Medixa Srl
Medixa Srl is an Italian pharmaceutical company specializing in the development and distribution of aesthetic medicine products, nutraceuticals, and dermatological solutions. With a commitment to scientific research, clinical safety, and innovative formulations, Medixa provides practitioners with advanced tools to support regenerative skin health. Ejal 40 exemplifies the company’s dedication to high-quality, effective, and patient-centered treatments that restore natural beauty through biorevitalization.